Clinical trials
Active, not recruiting Urogenital Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Dana-Farber Cancer Institute | 2 |
| Eli Lilly and Company | 2 |
| AgonOx, Inc. | 1 |
| Atavistik Bio, Inc | 1 |
| Centre of Postgraduate Medical Education | 1 |
| Endocyte | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| M.D. Anderson Cancer Center | 1 |
| Martine Puts | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urogenital Neoplasms | 21 |
| Prostatic Neoplasms | 7 |
| Neoplasms | 6 |
| Urinary Bladder Neoplasms | 6 |
| Breast Neoplasms | 5 |
| Neoplasms by Site | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Carcinoma, Renal Cell | 3 |
| Colorectal Neoplasms | 3 |
| Genital Neoplasms, Male | 3 |
Trials
Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.